Sugammadex NDC 67457-970

NDC codes

FDA NDC Directory

Product NDC (as listed)67457-970Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67457-0970Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67457-970-05	67457097005	10 VIAL, SINGLE-DOSE in 1 CARTON (67457-970-05) / 5 mL in 1 VIAL, SINGLE-DOSE (67457-970-00)Marketed from Jul 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sugammadex
Generic name (nonproprietary): sugammadex
Active ingredients: Sugammadex sodium — 100 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Mylan Institutional LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213915
Marketing start: Jul 28, 2026
Listing expires: Dec 31, 2027
Other FDA classes: gamma-Cyclodextrins (Chemical structure)
Identifiers: Product ID 67457-970_eb84def8-933b-4eba-b81f-30d40b1e3d8dSPL ID eb84def8-933b-4eba-b81f-30d40b1e3d8dSPL set ID eb84def8-933b-4eba-b81f-30d40b1e3d8dRxCUI 1726992, 1727000UNII ERJ6X2MXV7

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467457097005 followed by a unit qualifier and the quantity

Package 67457-0970-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 4, 2026.

Indications (excerpt from the label)

Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information. Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213915

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213915
Product	Strength	Form · route	Labeler	Product NDC
Sugammadex	Sugammadex sodium 100 mg/mL	Injection, SolutionIntravenous	Mylan Institutional LLC	67457-969